Biomarin Reflection
Biomarin researches and creates drugs to help cure orphan diseases. Biomarin was founded in 1997 by Christopher Starr Ph.D and Grant W Dennison Jr with a $1.5 million investment from Glyko Biomedical. It is the world leader in developing and commercializing innovative biopharmacutials for rare diseases. Of these diseases the patients are mostly consisting of children. I really liked this field trip because it was very interactive with us and we got to see some of the machines in action. We also had a lot of interaction with the workers themselves who taught roughly what they do on the job. Meeting these people made me reflect and help me know more about what i would like to when I'm older. I really hope we get to do more of these field trips in the future.